Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...
Singapore: Australia's QRxPharma has collaborated with Canadian specialty pharmaceutical company, Paladin Labs on licens...
Hyderabad: With emphasis on cutting-edge innovations this year, BioAsia 2014 under the theme 'Innovate. Evolve.' kick-st...
Singapore: Gilead Sciences' head of commercial operations for the past decade, Mr Kevin Young, who oversaw tremendous sa...
Singapore: Australian Prime Minister Mr Tony Abbott said that the nation is contracting a private company to staff and o...
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...
Singapore:Â The next Viralytics clinical study evaluating multi doses of CAVATAKÂ administered by the intravenous ro...
Singapore:Â Pharmaxis received a complete response letter from the US FDA confirming that Bronchitol cannot yet be app...
Singapore: Asia-Pacific, including Japan, China, India, New Zealand, South Korea and Australia, is the fastest growing r...
Singapore: CDC predicts that every year, one in every three adults in the age group of 65 or older falls and around 2 mi...
Industry forecasts by market analysts state that 80 percent of the multinational companies expect to gain a good share i...
Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...
Singapore: Australia boasts an advanced healthcare system supported by both the public and private sector involvement. T...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted orphan drug designation by t...
Singapore: US-Australian drug discovery company, Novogen's drug candidate, Anisina, has progressed successfully in pre-c...
Singapore: Australia-based Cynata Therapeutics has made a breakthrough by devising a technique to mass manufacture stem ...
Over the past decade the world's centre of economic gravity has shifted from US and Europe to Asia at a speed and scale ...
Singapore: CSL announced that it has clinched a deal with the Victorian government to expand its Melbourne plasma manufa...
Singapore: Telezon's flagship SoloFlow Reconstitution Needle (polymer needle) has been accepted by Therapeutic Goods Aus...
Singapore: Australia based Allied Healthcare has started commercializing CardioCel into Europe after the Company receive...
Singapore: 22nd Century Group, a company that has developed pioneering technology for tobacco harm reduction and smoking...
Singapore: Cancer Council NSW, Australia's non-government cancer research funder, has granted almost $7 million to resea...
Singapore: US-Australian drug discovery company, Novogen, in conjunction with Australian paediatric cancer researchers, ...
Singapore: Australian drug discovery company, Novogen, has developed anti-tropomyosin drug candidate, Anisina, which has...
Singapore: Australia-based Starpharma Holdings has achieved improved tumor-inhibiting efficacy and reduced overall toxic...
